Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2010 Jul 17;27(11):605–611. doi: 10.1007/s10815-010-9450-3

Cryo-survival, fertilization and early embryonic development of vitrified oocytes derived from mice of different reproductive age

Jie Yan 1,2, Joao Suzuki 1, Xiaomin Yu 1, Frederick W K Kan 3, Jie Qiao 2,, Ri-Cheng Chian 1,4,
PMCID: PMC2995429  PMID: 20640502

Abstract

Purpose

To evaluate the effect of female reproductive age on oocyte cryo-survival, fertilization and the subsequent embryonic development following vitrification using the mouse model in order to address the question of how maternal reproductive age is related to fertility preservation.

Methods

Oocytes were collected from mice of different reproductive age: (1) 8–10 weeks, (2) 16–20 weeks, (3) 32–36 weeks, and (4) 44–48 weeks. Following vitrification and warming, the oocytes in each group were assessed for cryo-survival, fertilization and embryonic development as well as for the quality of blastocysts. Fresh oocytes without undergoing vitrification were used in each age group as controls.

Results

The mean number of oocytes retrieved following superovulation was found to reduce significantly (P < 0.05) in mice from 32–36 weeks of age (18.1 ± 8.5) compared with 8–10 weeks of age (26.8 ± 9.8) and 16–20 weeks of age (23.9 ± 4.2) respectively. The cryo-survival rate of oocytes was reduced significantly (P < 0.05) in mice of 44–48 weeks of age (90.4% ± 7.9) compared with the other 3 groups (98.8% ± 2.1, 98.0% ± 3.3 and 98.5% ± 2.2, respectively). The cleavage rate of vitrified oocytes declined significantly following the increase in maternal age in mice of 32–36 weeks of age (69.7% ± 20.8) forward (63.6% ± 9.2). However, no significant difference in the cleavage rate was found among the control groups of different maternal ages. The rate of embryo development to the blastocyst stage in the vitrified oocytes also significantly declined following the increase in maternal age (71.8% ± 8.8, 66.4% ± 10.7, 64.2% ± 17.4 and 4.1% ± 8.3 respectively). There were no such differences in the rates of embryo development to the blastocyst stage among the control groups following the increase in maternal age (75.9% ± 12.2, 79.5% ± 28.9, 70.2% ± 17.4 and 69.3% ± 19.0 respectively). However, the quality of blastocysts produced from 32–36 weeks and 44–48 weeks of ages was significantly poor in term of total cell numbers and the ratio of inner cell mass(ICM) / trophectoderm (TE) compared to younger age in both vitrified and control groups

Conclusions

Cryo-survival of oocytes following vitrification and warming procedures is associated with female reproductive age. There is a more negative impact on the oocytes following vitrification and warming with the increase of maternal age.

Keywords: Female reproductive age, Oocytes, Cryo-survival, Fertilization, Embryonic development, Blastocyst

Introduction

In women, age-related decline of female fertility starts at the age of 30 s, markedly accelerates after 35 years of age, and fertility loss starts at a mean age of 41 years and completes by 50 years of age [13]. Studies on “natural populations” artificial insemination programs with donor sperm and in vitro fertilization (IVF) programs with women’s own oocytes have provided strong evidence for fertility decline during the third and fourth decades of life [46]. Although the primary cause for this decline is the gradual depletion of oocytes in aging ovary, it has been suggested that the decline of oocyte quality is also an important contributing factor [7]. Studies of older women (>40 years of age) undergoing IVF of donation with young oocytes indicated that oocyte quality decline is the major cause for infertility in older women, and oocyte age can even compensate for other age-related changes in the endocrine system and reproductive tract [8, 9]. Therefore, it appears that the quality of oocytes declines with maternal aging and affects embryonic development [3, 10, 11].

With the improvement of oocyte cryopreservation technologies, it is now possible to preserve female fertility having the oocyte cryopreserved prior to cancer treatment with cytotoxic chemotherapy or radiotherapy [12]. Oocyte cryopreservation would be a better option for women without a male partner. Recent experimental evidence indicated that, with the advancement made in oocyte vitrification technology, the use of cryopreserved oocytes have resulted in more and more healthy live births [1315]. Although oocyte cryopreservation is still considered an experimental procedure by the American Society for Reproductive Medicine [16, 17], today cancer patients, who are undergoing invasive cancer treatments and who wish to preserve their oocytes, are increasingly considering oocyte vitrification as a potential option for cryopreservation of their oocytes.

In addition, the idea of using Assisted Reproductive Technologies (ART) to conceive a child is appealing only to a minority of single women [18]. With the increasing opportunities for higher education, career advancement and economic independence, combined with the availability of highly effective contraception methods, more young women are delaying childbearing until the fourth decade of life regardless of the potential fertility decline [1, 19]. As a result, more and more women consider oocyte cryopreservation as a means to preserve their fertility even when they are already at the fourth decade of age. Apart from the association of declining quality of oocytes with maternal aging which also affects embryonic development, the effect of maternal age on cryo-survival, fertilization and embryonic development of vitrified oocytes is still largely unknown.

The objective of this study was to use the mouse model to examine the effect of female reproductive age on oocyte cryo-survival, fertilization and the subsequent embryonic development following vitrification in order to address the question of whether maternal reproductive age affects fertility preservation.

Materials and methods

Chemicals

All chemicals were obtained from Sigma Chemical Co. (St. Louis, MO) unless specified otherwise.

Oocyte collection and sperm preparation

The Animal Care Committee of McGill University approved all experiments involving the use of animals in this study. All mice (CD-1) were kept under specific-pathogen-free conditions with a humidity range of 30–60%, a temperature range of 21–24°C, a light cycle of 12 h light:12 h darkness, and were given free access to sterile food and water.

Female CD-1 mice were superovulated with an intraperitoneal injection of 10 IU of pregnant mare’s serum gonadotropin (PMSG), 48 h later followed by an intraperitoneal injection of 10 IU of human chorionic gonadotropin (HCG). Cumulus-oocytes-complexes (COCs) were collected from the ampullar region of oviducts 14 h after HCG injection. Cumulus cells were dispersed by 80 unit/mL of hyaluronidase for 1 min and removed by gently pipetting, and the denuded metaphase-II (M-II) oocytes were used for the experiments.

To collect sperm from the cauda epididymis, male CD-1 mice (10–14 weeks of age) were sacrificed by cervical dislocation, and both epididymides were dissected from the testes in their entirety. The contents in each cauda epididymis were squeezed out with a pair of forceps and transferred immediately into a pre-warmed drop (0.4 mL) of modified human tubal fluid (mHTF) containing 0.9% bovine serum albumin (BSA) for a 90-min incubation at 37°C in 5% CO2 in humidified air to induce sperm capacitation.

Oocyte vitrification and warming procedures

The vitrification and warming procedures were carried out as previously described [20]. Briefly, the oocytes were suspended for 3 min in an equilibration solution containing 7.5% ethylene glycol (EG), 7.5% 1.2-propanediol (PROH) and 10% fetal bovine serum (FBS) in Dulbecco’s phosphate buffered saline (DPBS). Afterwards the oocytes were transferred to vitrification solution (containing 15% EG, 15% PROH, 0.5 M sucrose and 10% FBS in DPBS) for 45–60 sec at room temperature, 4–5 oocytes were then loaded onto McGill Cryoleaf (MediCult Company, Denmark) and immediately plunged into liquid nitrogen for storage. For warming, the frozen McGill Cryoleaf carrying the oocytes was inserted directly into a thawing solution (containing 1.0 M sucrose in 10% FBS-supplemented DPBS) at 37°C for 1 min. The thawed oocytes were transferred to 0.5 M and 0.25 M sucrose in 10% FBS-supplemented DPBS for 3 min, respectively, and then washed twice with washing medium (10% FBS in DPBS) before they were transferred to culture medium at 37°C in 5% CO2 in humidified air. Cryo-survival rate of the oocytes was assessed 2 h after incubation, and cryo-survived oocytes were characterized by the morphological appearance of membrane integrity and discoloration of the ooplasm. The surviving oocytes were used further for the subsequent experiments.

Insemination with intracytoplasmic sperm injection (ICSI) and embryo culture in vitro

ICSI was performed using an Olympus microscope equipped with Narishigue micromanipulators and Piezo system (Prime Tech, Japan). After sperm capacitation, 5 μL of sperm suspension were added to a droplet consisted of 5 μL of 12% PVP solution under paraffin oil previously prepared in a 60-mm petri dish (FALCON, USA). Prior to ICSI, oocytes were transferred from mHTF medium into a droplet of Hepes buffered mHTF medium under paraffin oil. With the sperm/PVP suspension in the same dish, only highly motile sperm with a morphologically normal head were selected, and the head was separated from the tail by applying a few Piezo pulses. The sperm head was injected into the oocyte using a Piezo drive unit [21]. After injection, the oocytes were washed thoroughly with mHTF medium and then transferred into a droplet containing 50 μL of embryo maintenance medium (SAGE Media, USA) and cultured in the medium for 120–122 h under paraffin oil at 37°C in 5% CO2 in humidified air.

Assessment of the quality of blastocysts with differential staining

The number of inner cell mass (ICM) and trophectoderm (TE) cells in the blastocysts was determined with the method developed by Handyside and Hunter [22] with modifications. Briefly, the zona pellucida was removed from the blastocysts by culturing the latter in mHTF containing 0.5% protease for 15 min at 37°C in 5% CO2 in humidified air. After rinsing with 0.5% PVP/PBS for 5 min, the naked blastocysts were transferred to a solution containing rabbit anti-mouse splenocyte antiserum and Hepes-mHTF (1:3) for 20 min at 37°C in 5% CO2 in humidified air. The blastocysts were then washed 3 times each for 15 min with 0.5% PVP/PBS, and then immersed in a solution containing guinea pig complement and Hepes-mHTF (1:5) for another 20 min at 37°C in 5% CO2 in humidified air. After rinsing with 0.5% PVP/PBS, the blastocysts were incubated for 15 min at room temperature with a staining solution containing Hoechst 33342 (5 μg/mL) and Propidium iodide (5 μg/mL) in 0.5% PVP/PBS. The stained blastocysts were mounted on microscope slides with mounting medium. Following mounting, the number of ICM and TE cells was counted under UV light with blue filter. The nuclei in the TE cells showed a red-pink color while the nuclei in the ICM cells displayed a bluish color.

Experimental design

COCs were collected from mice of four different reproductive age groups: (1) 8–10 weeks, (2) 16–20 weeks, (3) 32–36 weeks, and (4) 44–48 weeks. Each experiment was repeated 5 times.

  1. Effect of reproductive age on the ovary in response to gonadotropin stimulation. Following stimulation with PMSG and HCG injection, the mean number of oocytes from each mouse was compared in each age group;

  2. Cryo-survival rate of the vitrified oocytes from different reproductive age. Following vitrification, the oocytes were stored in liquid nitrogen for at least 7 days. After thawing, the mean number of survived oocytes was compared in each age group;

  3. Fertilization and embryonic development of the vitrified oocytes derived from mice of different reproductive age. Following ICSI, fertilization (2-cell cleavage) rate was assessed 16–18 h after ICSI, and embryonic development to 8-cell stage was observed 70–72 h after ICSI. Blastocyst development was assayed 120–122 h after ICSI. Fresh oocytes without cryopreservation from each matched age group were collected and inseminated by ICSI as controls

  4. Quality of blastocysts produced by vitrified oocytes derived from mice of different reproductive age. The quality of blastocysts was evaluated by differential staining method following fixation at 96–98 h after ICSI. Fresh oocytes without cryopreservation from each matched age group were collected and inseminated by ICSI as controls.

Statistical analysis

The difference in the number of oocytes collected, the total cell number of blastocysts and the ratio of ICM/TE in each group were analyzed by ANOVA and a Fisher protected least significant difference test. The difference in oocyte cryo-survival, fertilization and embryonic development rates were analyzed by Chi-Square test, and quality control between each replicate were analyzed by ANOVA shown as mean±SD for different rates. The SPSS 17.0 statistical software package was employed in this analysis. Differences at P < 0.05 (two-tailed) were considered to be statistically significant.

Results

As shown in Table 1, the mean number of oocytes retrieved following superovulation was found to decrease significantly (P < 0.05) in mice of 32–36 weeks of age (18.1 ± 8.5) compared with the groups of 8–10 weeks of age (26.8 ± 9.8) and 16–20 weeks of age (23.9 ± 4.2). The mean number of oocytes (8.7 ± 4.0) collected from mice in the 44–48 weeks age group was found to be significantly lower than that of the other 3 groups.

Table 1.

Effect of mouse reproductive age on the ovary in response to gonadotropin stimulation (5 replicates)

Mouse age (weeks) No. of mice examined No. of oocytes retrieved No. (mean) of oocytes from each mouse 95% confidence interval (CI)
8–10 18 483 26.8 ± 9.8a 21.9∼31.7
16–20 14 335 23.9 ± 4.3a 21.4∼26.4
32–36 17 309 18.1 ± 8.5b 13.7∼22.5
44–48 27 256 8.7 ± 4.0c 4.5∼10.1

a–cDifferent superscripts indicate significant difference (P < 0.05)

Cryo-survival rate of the oocytes was reduced significantly (P < 0.05) in mice of the 44–48 weeks age group (90.4% ± 7.9) compared with the other 3 groups (98.8% ± 2.1, 98.0% ± 3.3 and 98.5% ± 2.2, respectively) (Table 2). However, there were no differences found in the oocyte cryo-survival rate in mice of the 8–10, 16–20 and 32–36 weeks age groups.

Table 2.

Cryo-survival rate of vitrified oocytes from mice of different reproductive age (5 replicates)

Mouse age (weeks) No. of oocytes vitrified No. of oocytes survived Survival rate (mean%±SD) 95% confidence interval (CI)
8–10 300 296 98.8 ± 2.1a 97.6∼100.1
16–20 220 217 98.0 ± 3.3a 95.8∼100.3
32–36 198 195 98.5 ± 2.2a 67.1∼100.2
44–48 144 133 90.4 ± 7.9b 83.1∼97.8

a–bDifferent superscripts indicate significant difference (P < 0.05)

As shown in Table 3, the cleavage rate of the vitrified oocytes declined significantly following the increase in maternal age starting from mice of 32–36 weeks of age (69.7% ± 20.8) to mice of 44–48 weeks of age (63.6% ± 9.2) compared with the mice in the 8–10 weeks (90.7% ± 13.7) and 16–20 weeks (91.9% ± 10.5) age groups and the control oocytes without vitrification (91.5% ± 6.9, 94.2% ± 2.0, 91.9% ± 5.8 and 89.7% ± 5.1, respectively). Similarly, the rate of embryos developed from the vitrified oocytes to 8-cell stage decreased significantly in mice in the 16–20 weeks age group (70.0% ± 4.8) with a further decrease in the 32–36 weeks (70.2% ± 15.6) and 44–48 weeks age groups (8.3% ± 16.6) compared with the mice of 8–10 weeks old (87.8% ± 10.3) and the corresponding groups of control oocytes without vitrification (88.8% ± 5.8, 85.5% ± 18.7, 80.6% ± 12.3 and 81.0 ± 11.6, respectively). Finally, the rate of embryo development from vitrified oocytes to the blastocyst stage declined significantly following the increase in maternal age of the animals (71.8% ± 8.8, 66.4% ± 10.7, 64.2% ± 17.4 and 4.1% ± 8.3, respectively). However, there were no differences found in the rate of embryo development in the control groups of oocytes without undergoing prior vitrification (75.9% ± 12.2, 79.5% ± 28.9, 70.2% ± 17.4 and 69.3% ± 19.0, respectively).

Table 3.

Fertilization and embryonic development of vitrified oocytes from mice of different reproductive age (5 replicates)

Mouse age (wks) Oocytes with(+) or without (−) vitrification No. of oocytes inseminated No. of oocytes cleaved (%) No. of embryos developed to 8-cell stage (mean%±SD) No. of embryos developed to blastocyst stage (mean%±SD)
8–10 + 71 62 (90.7 ± 13.7)a 53 (87.8 ± 10.3)a 44 (71.8 ± 8.8)a
72 68 (91.5 ± 6.9)a 59 (88.8 ± 5.8)a 48 (75.9 ± 12.2)a
16–20 + 68 64 (91.9 ± 10.5)a 43 (70.0 ± 4.8)b 38 (66.4 ± 10.7)ac
72 68 (94.2 ± 2.0)a 56 (85.5 ± 18.7)a 51 (79.5 ± 28.9)a
32–36 + 62 38 (69.7 ± 20.8)b 29 (70.2 ± 15.6)b 27 (64.2 ± 17.4)bc
86 80 (91.9 ± 5.8)a 63 (80.6 ± 12.3)a 54 (70.2 ± 17.4)a
44–48 + 60 41 (63.6 ± 9.2)b 8 (8.3 ± 16.6)c 4 (4.1 ± 8.3)d
97 87 (89.7 ± 5.1)a 68 (81.0 ± 11.6)a 56 (69.3 ± 19.0)a

a–dDifferent superscripts indicate significant difference within the same column (P < 0.05)

Table 4 shows the quality of blastocysts produced by oocytes derived from mice of different reproductive age. The total cell numbers in each blastocyt decreased significantly in those derived from vitrified oocytes of 32–36 weeks of age (59.8 ± 29.3) and was found to be further reduced in the oocytes in the 44–48 weeks age group (43.2 ± 37.3) compared with the vitrified oocytes in the 8–10 weeks (94.2 ± 41.3) and 16–20 weeks (85.8 ± 46.0) age groups. However, no significant differences were found in the total cell number of blastocysts between the vitrified oocytes and the control oocytes regardless of the age group. Although there were no differences in the ratio of ICM/TE in the blastocysts between the vitrified oocytes and the control oocytes from the 8–10 weeks (17.3% ± 16.2 vs. 22.6% ± 18.4) and 16–20 weeks (20.9% ± 12.3 vs. 23.9% ± 14.3) of age, the ratio of ICM/TE was significantly reduced in the vitrified oocytes in mice of 32–36 weeks (8.7% ± 9.9) and 44–48 weeks (9.1% ± 9.7) of age compared to the control oocyte groups (22.8% ± 12.8 and 24.2% ± 2.9, respectively).

Table 4.

Quality of blastocysts produced by vitrified oocytes from mice of different reproductive age

Mouse age (wks) Oocytes with (+) or without (−) vitrification No. of blastocysts examined Total cell numbers in each blastocyst (mean±SD) Ratio of ICM/TE (mean%±SD)
8–10 + 22 94.2 ± 41.3a 17.3 ± 16.2a
20 99.1 ± 44.2a 22.6 ± 18.4a
16–20 + 22 85.8 ± 46.0a 20.9 ± 12.3a
25 85.9 ± 38.8a 23.9 ± 14.3a
32–36 + 24 59.8 ± 29.3b 8.7 ± 9.9b
21 61.7 ± 37.2b 22.8 ± 12.8a
44–48 + 4 43.2 ± 37.3c 9.1 ± 9.7b
30 46.3 ± 17.6c 24.2 ± 2.9a

a–cDifferent superscripts indicate significant difference within the same column (P < 0.05)

Discussion

The reproductive life span of female mice is strain specific. It usually starts at the age of 6 weeks post-natal and lasts up to 12–14 months [23]. This study revealed that adult mouse ovarian response to gonadotropin stimulation declines with increasing reproductive age as shown by the decrease in the number of oocytes collected (Table 1). Our observation support the findings of a previous study showing that the number of oocytes retrieved declined with increased mouse maternal age [24]. The mechanism of poor ovarian response to gonadotropin stimulation is not clear at the present time. However, it is reasonable to believe that the deletion of ovarian reservation is the main cause for the fertility decline. It has been reported that the number of primordial and growing follicles in the mouse ovary is nearly exhausted by 13–14 months [2527].

Although several previous studies reported that the quality of oocytes is associated with maternal age [10, 2832], prior to the present study there has not been any report indicating whether cryo-survival of oocytes is related to maternal age of the oocyte. Ultrastructural abnormalities have been found in correlation with increase in maternal reproductive age of mouse oocytes [24]. Results of the present study demonstrated for the first time that cryo-survival of oocytes is related to maternal age, revealing that the cryo-survival rate of mouse oocytes significantly declined in oocytes retrieved from mice of 40–44 weeks of age (Table 2). The reproductive life span of female mice is strain specific, but it usually lasts up to 12–14 months [23]. Mice over 40 weeks of age are already near the end of their reproductive life span, and they bear smaller litters and have less implantation sites than younger females. Therefore, it is important to note that the maternal reproductive age is associated with not only the poor quality of the oocytes but also with cryo-survival following vitrification. It appears that oocytes derived from mice of advanced maternal reproductive age are more sensitive to extracellular stress compared to oocytes derived from younger females.

No significant differences were found in the cleavage rate and embryonic development of oocytes derived from mice of different reproductive age without vitrification (Table 3). Our findings are in line with the hypothesis put forth in previous reports [5, 33]. However, the present study demonstrated that the rate of cleavage was significantly reduced in vitrified oocytes of the 32–36 weeks age group, and embryonic development (8-cell stage and blastocyst stage) was significantly reduced in vitrified oocytes of the 16–20 weeks age group, indicating that the vitrification and warming procedures have an adverse effect on oocyte fertilization and embryonic development. Interestingly the present results indicated that the detrimental affects seem to be directly related to the maternal reproductive age of the vitrified oocytes, suggesting that vitrification and warming procedures may have caused some damages to the oocytes and that the damages are likely associated with the advanced maternal age.

Oocyte quality can also be assessed by the total cell number of blastocysts and the ratio of ICM/TE [34]. Results of the present study indicated that although the total cell number of blastocysts is related to the maternal age of the oocytes rather than the vitrification and warming procedures, the ratio of ICM/TE in blastocysts is related not only to the maternal reproductive age but also to the vitrification and warming procedures (Table 4). It has been known that DNA fragmentation is significantly higher in oocytes of aged mice compared with younger adult mice [35]. This DNA damage can be exacerbated by cryopreservation [36, 37]. A significant DNA fragmentation has been found in vitrified bovine oocytes [38]. It has been reported that the process of oocyte vitrification can induce profound modifications to mitochondria, cortical granules, microvilli, oolemma, smooth endoplasmic reticulum (SER) and cytoskeleton [3943]. Therefore, taken together, it appears that the quality of blastocysts is detrimentally affected by both maternal reproductive age and vitrification/ warming procedures.

There is a paucity of information about the effect of maternal reproductive age on the pregnancy outcome of vitrified oocytes. It has been reported that in humans with increasing maternal reproductive age, a decrease of mitochondria in the ooplasmic fraction, dilation of SER and Golgi complex, and an increase in vacuolarization occurs in the oocytes [44]. Although it has been reported that a woman of 40 years of age gave live birth successfully following cryopreservation of her own oocytes [45], it should be taken into consideration that the quality of the oocytes are related not only to the maternal reproductive age but also to the vitrification and warming procedures. Both of the advanced reproductive age and the vitrification and warming procedures will synergistically affect the oocyte cryo-survival, fertilization and embryonic development. Therefore, it is important to emphasize here that the age limitation of women should be considered before utilizing cryopreservation of oocytes for different purposes in assisted reproductive technology.

Conclusions

The present study has demonstrated for the first time that oocyte cryo-survival following vitrification and warming procedures is directly related to the female reproductive age. Oocytes derived from mice of advanced maternal reproductive age are more sensitive to extracellular stress when compared to oocytes derived from younger females, resulting in reduced cryo-survival, fertilization and embryonic development.

Acknowledgments

Dr. J. Yan was supported by the China Scholarship Council (file No. 2008601206) with the State Scholarship Fund to pursue her studies in Canada. This research project was funded by the McGill Reproductive Center, McGill University Health Center (MUHC), Montreal, Canada

Footnotes

Capsule

Reduction in fertilization rate and poor embryonic development following vitrification procedure has been found to be associated with increased reproductive age.

Contributor Information

Jie Qiao, FAX: +86-10-82265438, Email: jie.qiao@263.net.

Ri-Cheng Chian, FAX: +1-514-8431662, Email: ri-cheng.chian@muhc.mcgill.ca.

References

  • 1.Noord-Zaadstra BM, Looman CW, Alsbach H, Habbema JD, Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361–5. doi: 10.1136/bmj.302.6789.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ottolenghi C, Uda M, Hamatani T, Crisponi L, Garcia JE, Ko M, et al. Aging of oocyte, ovary, and human reproduction. Ann NY Acad Sci. 2004;1034:117–31. doi: 10.1196/annals.1335.015. [DOI] [PubMed] [Google Scholar]
  • 3.Armstrong DT. Effects of maternal age on oocyte developmental competence. Theriogenology. 2001;55:1303–22. doi: 10.1016/s0093-691x(01)00484-8. [DOI] [PubMed] [Google Scholar]
  • 4.Klein J, Sauer MV. Assessing fertility in women of advanced reproductive age. Am J Obstet Gynecol. 2001;185:758–70. doi: 10.1067/mob.2001.114689. [DOI] [PubMed] [Google Scholar]
  • 5.Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med. 1982;306:404–6. doi: 10.1056/NEJM198202183060706. [DOI] [PubMed] [Google Scholar]
  • 6.Kooij RJ, Looman CW, Habbema JD, Dorland M, Velde ER. Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril. 1996;66:769–75. doi: 10.1016/s0015-0282(16)58634-8. [DOI] [PubMed] [Google Scholar]
  • 7.Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54. doi: 10.1093/humupd/8.2.141. [DOI] [PubMed] [Google Scholar]
  • 8.Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT, Jr, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril. 1994;61:97–101. doi: 10.1016/s0015-0282(16)56459-0. [DOI] [PubMed] [Google Scholar]
  • 9.Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337:1375–7. doi: 10.1016/0140-6736(91)93060-m. [DOI] [PubMed] [Google Scholar]
  • 10.Volarcik K, Sheean L, Goldfarb J, Woods L, Abdul-Karim FW, Hunt P. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod. 1998;13:154–60. doi: 10.1093/humrep/13.1.154. [DOI] [PubMed] [Google Scholar]
  • 11.Krisher RL. The effect of oocyte quality on development. J Anim Sci. 2004;82(E-Suppl):E14–23. doi: 10.2527/2004.8213_supplE14x. [DOI] [PubMed] [Google Scholar]
  • 12.Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008;89:567–72. doi: 10.1016/j.fertnstert.2007.03.090. [DOI] [PubMed] [Google Scholar]
  • 13.Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70–80. doi: 10.1016/j.fertnstert.2006.03.017. [DOI] [PubMed] [Google Scholar]
  • 14.Cobo A, Kuwayama M, Perez S, Ruiz A, Pellicer A, Remohi J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89:1657–64. doi: 10.1016/j.fertnstert.2007.05.050. [DOI] [PubMed] [Google Scholar]
  • 15.Wei YH, Wu SB, Ma YS, Lee HC. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J. 2009;32:113–32. [PubMed] [Google Scholar]
  • 16.Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241–6. doi: 10.1016/j.fertnstert.2008.08.039. [DOI] [PubMed] [Google Scholar]
  • 17.Maher B. Little consensus on egg freezing. Nature. 2007;449:958. doi: 10.1038/449958a. [DOI] [PubMed] [Google Scholar]
  • 18.Broekmans FJ, Knauff EA, Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab. 2007;18:58–65. doi: 10.1016/j.tem.2007.01.004. [DOI] [PubMed] [Google Scholar]
  • 19.Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril. 1991;56:192–3. [PubMed] [Google Scholar]
  • 20.Huang JY, Chen HY, Park JY, Tan SL, Chian RC. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril. 2008;90:1424–32. doi: 10.1016/j.fertnstert.2007.07.1335. [DOI] [PubMed] [Google Scholar]
  • 21.Kimura Y, Yanagimachi R. Intracytoplasmic sperm injection in the mouse. Biol Reprod. 1995;52:709–20. doi: 10.1095/biolreprod52.4.709. [DOI] [PubMed] [Google Scholar]
  • 22.Handyside AH, Hunter S. A rapid procedure for visualising the inner cell mass and trophectoderm nuclei of mouse blastocysts in situ using polynucleotide-specific fluorochromes. J Exp Zool. 1984;231:429–34. doi: 10.1002/jez.1402310317. [DOI] [PubMed] [Google Scholar]
  • 23.Rugh R. The mouse. Its reproduction and development. Oxford University Press; 1990, P5.
  • 24.Tarin JJ, Perez-Albala S, Cano A. Cellular and morphological traits of oocytes retrieved from aging mice after exogenous ovarian stimulation. Biol Reprod. 2001;65:141–50. doi: 10.1095/biolreprod65.1.141. [DOI] [PubMed] [Google Scholar]
  • 25.Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R, et al. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod. 1997;12:1028–31. doi: 10.1093/humrep/12.5.1028. [DOI] [PubMed] [Google Scholar]
  • 26.Gosden RG, Laing SC, Felicio LS, Nelson JF, Finch CE. Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice. Biol Reprod. 1983;28:255–60. doi: 10.1095/biolreprod28.2.255. [DOI] [PubMed] [Google Scholar]
  • 27.Faddy MJ, Gosden RG. A mathematical model of follicle dynamics in the human ovary. Hum Reprod. 1995;10:770–5. doi: 10.1093/oxfordjournals.humrep.a136036. [DOI] [PubMed] [Google Scholar]
  • 28.Levran D, Ben-Shlomo I, Dor J, Ben-Rafael Z, Nebel L, Mashiach S. Aging of endometrium and oocytes: observations on conception and abortion rates in an egg donation model. Fertil Steril. 1991;56:1091–4. doi: 10.1016/s0015-0282(16)54722-0. [DOI] [PubMed] [Google Scholar]
  • 29.Balmaceda JP, Bernardini L, Ciuffardi I, Felix C, Ord T, Sueldo CE, et al. Oocyte donation in humans: a model to study the effect of age on embryo implantation rate. Hum Reprod. 1994;9:2160–3. doi: 10.1093/oxfordjournals.humrep.a138410. [DOI] [PubMed] [Google Scholar]
  • 30.Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484–6. doi: 10.1093/oxfordjournals.humrep.a019422. [DOI] [PubMed] [Google Scholar]
  • 31.Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril. 1995;64:382–91. [PubMed] [Google Scholar]
  • 32.Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996;11:2217–22. doi: 10.1093/oxfordjournals.humrep.a019080. [DOI] [PubMed] [Google Scholar]
  • 33.Lopes FL, Fortier AL, Darricarrere N, Chan D, Arnold DR, Trasler JM. Reproductive and epigenetic outcomes associated with aging mouse oocytes. In: Hum Mol Genet, vol. 18; 2009: 2032–2044. [DOI] [PubMed]
  • 34.Wang Y, Ock SA, Chian RC. Effect of gonadotrophin stimulation on mouse oocyte quality and subsequent embryonic development in vitro. Reprod Biomed Online. 2006;12:304–14. doi: 10.1016/s1472-6483(10)61002-4. [DOI] [PubMed] [Google Scholar]
  • 35.Fujino Y, Ozaki K, Yamamasu S, Ito F, Matsuoka I, Hayashi E, et al. DNA fragmentation of oocytes in aged mice. Hum Reprod. 1996;11:1480–3. doi: 10.1093/oxfordjournals.humrep.a019421. [DOI] [PubMed] [Google Scholar]
  • 36.Bouquet M, Selva J, Auroux M. Cryopreservation of mouse oocytes: mutagenic effects in the embryo? Biol Reprod. 1993;49:764–9. doi: 10.1095/biolreprod49.4.764. [DOI] [PubMed] [Google Scholar]
  • 37.Men H, Monson RL, Parrish JJ, Rutledge JJ. Detection of DNA damage in bovine metaphase II oocytes resulting from cryopreservation. Mol Reprod Dev. 2003;64:245–50. doi: 10.1002/mrd.10249. [DOI] [PubMed] [Google Scholar]
  • 38.Stachowiak EM, Papis K, Kruszewski M, Iwanenko T, Bartlomiejczyk T, Modlinski JA. Comparison of the level(s) of DNA damage using Comet assay in bovine oocytes subjected to selected vitrification methods. Reprod Domest Anim. 2009;44:653–8. doi: 10.1111/j.1439-0531.2007.01042.x. [DOI] [PubMed] [Google Scholar]
  • 39.Fuku E, Xia L, Downey BR. Ultrastructural changes in bovine oocytes cryopreserved by vitrification. Cryobiology. 1995;32:139–56. doi: 10.1006/cryo.1995.1013. [DOI] [PubMed] [Google Scholar]
  • 40.Boonkusol D, Faisaikarm T, Dinnyes A, Kitiyanant Y. Effects of vitrification procedures on subsequent development and ultrastructure of in vitro-matured swamp buffalo (Bubalus bubalis) oocytes. Reprod Fertil Dev. 2007;19:383–91. doi: 10.1071/rd06097. [DOI] [PubMed] [Google Scholar]
  • 41.Gualtieri R, Iaccarino M, Mollo V, Prisco M, Iaccarino S, Talevi R. Slow cooling of human oocytes: ultrastructural injuries and apoptotic status. Fertil Steril. 2009;91:1023–34. doi: 10.1016/j.fertnstert.2008.01.076. [DOI] [PubMed] [Google Scholar]
  • 42.Rho GJ, Kim S, Yoo JG, Balasubramanian S, Lee HJ, Choe SY. Microtubulin configuration and mitochondrial distribution after ultra-rapid cooling of bovine oocytes. Mol Reprod Dev. 2002;63:464–70. doi: 10.1002/mrd.10196. [DOI] [PubMed] [Google Scholar]
  • 43.Valojerdi MR, Salehnia M. Developmental potential and ultrastructural injuries of metaphase II (MII) mouse oocytes after slow freezing or vitrification. J Assist Reprod Genet. 2005;22:119–27. doi: 10.1007/s10815-005-4876-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bruin JP, Dorland M, Spek ER, Posthuma G, Haaften M, Looman CW, et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod. 2004;70:419–24. doi: 10.1095/biolreprod.103.015784. [DOI] [PubMed] [Google Scholar]
  • 45.Parmegiani L, Cognigni GE, Bernardi S, Ciampaglia W, Pocognoli P, Filicori M. Birth of a baby conceived from frozen oocytes of a 40-year-old woman. Reprod Biomed Online. 2009;18:795–8. doi: 10.1016/s1472-6483(10)60028-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES